Department of Otorhinolaryngology, College of Medicine, Konyang University Hospital, Konyang University, Daejeon 35365, Korea.
Department of Otolaryngology, School of Medicine, Ajou University, Suwon 16499, Korea.
Exp Biol Med (Maywood). 2021 Mar;246(6):718-728. doi: 10.1177/1535370220974269. Epub 2020 Dec 6.
Intractable wound healing is the habitual problem of diabetes mellitus. High blood glucose limits wound healing by interrupting inflammatory responses and inhibiting neoangiogenesis. Oxidative stress is commonly thought to be a major pathogenic cause of diabetic complications. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one, EDV) is a free radical scavenger which suppress oxidative stress. This study investigates whether EDV can reduce oxidative stress in wound healing HaCaT/human dermal fibroblasts cells (HDFs) and animal model. Cell viability and wound healing assays, FACS flow cytometry, and Hoechst 33342 staining were performed to confirm apoptosis and cytotoxicity in HO and EDV-treated HaCaT and HDFs. A streptozotocin-induced hyperglycemic animal model was made in adult C57BL6 mice. Full-thickness skin flap was made on dorsomedial back and re-sutured to evaluate the wound healing process. EDV was delivered slowly in the skin flap with degradable fibrin glue. The flap was monitored and analyzed on postoperative days 1, 3, and 5. CD31/DAPI staining was done to detect newly formed blood vessels. The expression levels of NF-κB, bcl-2, NOX3, and STAT3 proteins in C57BL6 mouse tissues were also examined. The wound healing process in hyper- and normoglycemic mice showed a difference in protein expression, especially in oxidative stress management and angiogenesis. Exogenous HO reduced cell viability in a proportion to the concentration via apoptosis. EDV protected HaCaT cells and HDFs from HO induced reactive oxygen species cell damage and apoptosis. In the mouse model, EDV with fibrin resulted in less necrotic areas and increased angiogenesis on postoperative day 5, compared to sham-treated mice. Our results indicate that EDV could protect HO-induced cellular injury via inhibiting early apoptosis and inflammation and also increasing angiogenesis. EDV might be valuable in the treatment of diabetic wounds that oxidative stress has been implicated.
难治性创面愈合是糖尿病的常见问题。高血糖通过中断炎症反应和抑制新生血管生成来限制创面愈合。氧化应激通常被认为是糖尿病并发症的主要致病原因。依达拉奉(3-甲基-1-苯基-2-吡唑啉-5-酮,EDV)是一种自由基清除剂,可抑制氧化应激。本研究旨在探讨 EDV 是否可减少创面愈合 HaCaT/人真皮成纤维细胞(HDF)和动物模型中的氧化应激。通过细胞活力和创面愈合测定、FACS 流式细胞术和 Hoechst 33342 染色来证实 HO 和 EDV 处理的 HaCaT 和 HDF 中的细胞凋亡和细胞毒性。采用链脲佐菌素诱导的成年 C57BL6 小鼠高血糖动物模型。在背内侧背部制作全厚皮瓣,并重新缝合以评估创面愈合过程。用可降解纤维蛋白胶缓慢递送至皮瓣内。在术后第 1、3 和 5 天监测和分析皮瓣。用 CD31/DAPI 染色检测新形成的血管。还检测了 C57BL6 小鼠组织中 NF-κB、bcl-2、NOX3 和 STAT3 蛋白的表达水平。高血糖和正常血糖小鼠的创面愈合过程在蛋白表达方面存在差异,尤其是在氧化应激管理和血管生成方面。外源性 HO 通过凋亡使细胞活力按比例降低。EDV 可保护 HaCaT 细胞和 HDF 免受 HO 诱导的活性氧细胞损伤和凋亡。在小鼠模型中,与假手术处理的小鼠相比,纤维蛋白结合 EDV 在术后第 5 天导致更少的坏死区域和增加的血管生成。我们的结果表明,EDV 可通过抑制早期凋亡和炎症以及增加血管生成来保护 HO 诱导的细胞损伤。EDV 可能对涉及氧化应激的糖尿病创面具有治疗价值。